New valve procedure aims to fix leaky heart in pump patients

NCT ID NCT07363473

Not yet recruiting Disease control Sponsor: JC Medical, Inc., an affiliate of Edwards Lifesciences LLC Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new device called the J-Valve Transfemoral System in 50 adults who have a heart pump (LVAD) and a severely leaking aortic valve. The valve is replaced through a blood vessel, avoiding open-heart surgery. The goal is to see if it safely stops the leak and improves heart function and survival.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: J-Valve Transfemoral System (a replacement heart valve delivered through a blood vessel)
What this could lead to: If it works, this could offer a less invasive way to fix a leaking aortic valve in people who already have a heart pump, potentially improving their heart function and quality of life.
What could go wrong: This is an early study with only 50 participants, so results may not apply to everyone. Risks include valve movement, need for a second valve, or death.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC INSUFFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve disorder aortic valve insufficiency

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC INSUFFICIENCY AORTIC VALVE DISEASE MIXED AORTIC VALVE REGURGITATION

More trials for these conditions

Other studies related to the condition(s) this trial covers.